gptkbp:instance_of
|
gptkb:drug
|
gptkbp:bfsLayer
|
6
|
gptkbp:bfsParent
|
gptkb:Plasmodium_falciparum
gptkb:Plasmodium_knowlesi
gptkb:Plasmodium_ovale
|
gptkbp:appointed_by
|
injections
oral tablets
|
gptkbp:can_be_used_with
|
non-artemisinin drugs
|
gptkbp:caused_by
|
hypersensitivity reactions
QT prolongation
|
gptkbp:collaborated_with
|
research institutions
|
gptkbp:developed_by
|
gptkb:artemisinin
|
gptkbp:first_introduced
|
1990s
|
gptkbp:formulation
|
co-packaged therapies
fixed-dose combinations
|
https://www.w3.org/2000/01/rdf-schema#label
|
artemisinin-based combination therapy
|
gptkbp:improves
|
treatment adherence
|
gptkbp:includes
|
gptkb:artemisinin
gptkb:dihydroartemisinin
gptkb:lumefantrine
gptkb:mefloquine
gptkb:piperaquine
|
gptkbp:is_analyzed_in
|
cost-effectiveness
|
gptkbp:is_associated_with
|
reduced transmission
|
gptkbp:is_challenged_by
|
drug resistance
|
gptkbp:is_discussed_in
|
gptkb:academic_journal
scientific conferences
|
gptkbp:is_effective_against
|
gptkb:Plasmodium_falciparum
|
gptkbp:is_evaluated_by
|
gptkb:municipality
safety and efficacy
public health studies
|
gptkbp:is_influenced_by
|
drug policy changes
|
gptkbp:is_informed_by
|
epidemiological data
|
gptkbp:is_linked_to
|
improved patient outcomes
|
gptkbp:is_monitored_by
|
cardiac effects
|
gptkbp:is_part_of
|
treatment protocols
treatment regimens
malaria control strategies
global malaria eradication efforts
|
gptkbp:is_promoted_by
|
healthcare providers
public health campaigns
|
gptkbp:is_studied_in
|
resistance patterns
|
gptkbp:is_subject_to
|
clinical trials
regulatory approvals
|
gptkbp:is_supported_by
|
research funding
international health organizations
|
gptkbp:is_used_for
|
treating malaria
|
gptkbp:is_used_in
|
gptkb:Southeast_Asia
gptkb:sub-Saharan_Africa
tropical regions
|
gptkbp:is_utilized_in
|
treatment guidelines
|
gptkbp:reduces
|
malaria mortality
|
gptkbp:requires
|
diagnosis of malaria
|
gptkbp:side_effect
|
dizziness
headache
nausea
vomiting
|
gptkbp:suitable_for
|
gptkb:World_Health_Organization
gptkb:CDC
monotherapy
uncomplicated malaria
|